Heather K. Beasley was among the researchers who visited Washington, D.C to push for sustained NIH funding during AACR...
Back for the new decade is our regular staple: the monthly collection of 10 “must read” articles that have...
The first new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) in 2020 are for the...
The advent of immunotherapy has led to durable responses for an increasing number of patients, including many who initially...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....
The U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called fam-trastuzumab deruxtecan-nxki (Enhertu) for treating...
The new year began with the good news that death rates from cancer are continuing their steady decline. A...
Around 400 BC, the Greek physician Hippocrates is believed to have first described tumors as “cancer,” using the words...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
In 2019, research continued to drive progress across the spectrum of cancer care in the form of new and...
In November and the first half of December, the U.S. Food and Drug Administration (FDA) announced three approvals for...